TUESDAY, Oct. 8, 2024 (HealthDay News) — A recently approved targeted chemotherapy drug can significantly extend the lives of advanced breast cancer patients who have developed tumors in their brains, new clinical trial results show. On average, patients receiving the drug Enhertu (trastuzumab deruxtecan) survived more than 17 months withoutContinue Reading
MONDAY, Oct. 7, 2024 (HealthDay News) — A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer. A phase 3 clinical trial has shown that circulating tumor cell (CTC) counts can predict which men are likely to respond to standard treatmentContinue Reading
MONDAY, Oct. 7, 2024 (HealthDay News) — Two new studies show insurers continue to deny claims for preventive care that is supposed to be free under Obamacare. And insurers are more apt to reject claims from patients who are Asian, Black or Hispanic as well as those with low incomes,Continue Reading
SATURDAY, Oct. 5, 2024 (HealthDay News) — Breast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone. To cope with such devastating news, breast cancer surgeons from the American College of Surgeons (ACS) offer tips on navigatingContinue Reading
FRIDAY, Oct. 4, 2024 (HealthDay News) — Colon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begin at the age of 45, not 50 as had been previously recommended. Now, research shows the new guideline may have led to a triplingContinue Reading
FRIDAY, Oct. 4, 2024 (HealthDay News) — Growing up in a city with pockets of high radon levels, Matthew Bozigar wondered whether the radioactive gas might have anything to do with the high rates of cancer he saw around him, especially in young people. “As an epidemiologist, I started consideringContinue Reading
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — The short but much-loved life of a French bulldog named George leaves a legacy of learning for those who care for animals and humans. George’s owner Louis Tavares, of Windemere, Fla., brought him to doctors at the University of Florida’s College of VeterinaryContinue Reading
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Most Americans are eating their way to inflammation that puts them at risk of cancer, heart disease and other serious health problems, a new study shows. “Overall, 57% of U.S. adults have a pro-inflammatory diet and that number was higher for Black Americans,Continue Reading
TUESDAY, Oct. 1, 2024 (HealthDay News) — Food left in the stomach or stool left in the bowel can impede a doctor’s ability to successfully perform an endoscopy or colonoscopy. Now, research finds this scenario is more likely if the patient is taking popular new weight-loss meds such as Ozempic,Continue Reading
TUESDAY, Oct. 1, 2024 (HealthDay News) — While women overall are less likely to die of breast cancer now, some alarming disparities remain, a new American Cancer Society (ACS) analysis warns. Death rates for American Indian and Alaska Native women haven’t changed for the past 30 years, according to theContinue Reading
TUESDAY, Oct. 1, 2024 (HealthDay News) — Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study examining its use in a community setting has found. CAR-T is shorthand for chimeric antigen receptor therapy. In this treatment, doctors remove the patient’s own whiteContinue Reading
TUESDAY, Oct. 1, 2024 (HealthDay News) — Blood cancer patients of all races who receive cord blood transplants are now living longer. The finding, reported by a team led by oncologist Dr. Karen Ballen, of UVA (University of Virginia) Health, shows that a previously identified survival gap for transplant recipientsContinue Reading
TUESDAY, Oct. 1, 2024 (HealthDay News) — Clinical trials sponsored by Big Pharma enrolled eight times as many patients as U.S.-government trials did between 2018 and 2022, new research shows. The study — conducted by researchers at Fred Hutch Cancer Center in Seattle — underscores the lack of investment inContinue Reading
MONDAY, Sept. 30, 2024 (HealthDay News) — A shorter course of post-mastectomy radiation doesn’t jeopardize a patient’s chances of successful breast reconstruction, a new study finds. About 40 percent of people with breast cancer have mastectomies, followed by five to six weeks of radiation therapy to kill any cancer cellsContinue Reading